{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:20:00Z","timestamp":1787498400725,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, with up to 90% of females infected at some point in their lifetime. While most HPV infections will be cleared by the immune system within 2 years, persistent HPV infection may result in anogenital warts, dysplasia of the cervix, vagina, vulva, and squamous cell carcinoma. This chapter will review the epidemiology, microbiology, progression, and treatment of HPV-related genital disease in women.<\/jats:p>","DOI":"10.1097\/grf.0000000000000930","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:00:14Z","timestamp":1740618014000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Human Papillomavirus Infections and Sequela in Women"],"prefix":"10.1097","volume":"68","author":[{"given":"Mary J.","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina R.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"R1-20250516","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"R2-20250516","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0002-9378(91)90101-V","article-title":"High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection","volume":"165","author":"Vermund","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20250516","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-20250516","first-page":"2","article-title":"Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine","volume":"1","author":"Braaten","year":"2008","journal-title":"Rev Obstet Gynecol Winter"},{"key":"R6-20250516","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-20250516","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"R10-20250516","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"R11-20250516","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/GRF.0000000000000132","article-title":"Vulvar intraepithelial neoplasia (VIN) and condylomata","volume":"58","author":"Nelson","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"R12-20250516","first-page":"25","article-title":"Genital warts: a comprehensive review","volume":"5","author":"Yanofsky","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"R13-20250516","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.coviro.2013.06.003","article-title":"Latent papillomavirus infections and their regulation","volume":"3","author":"Doorbar","year":"2013","journal-title":"Curr Opin Virol"},{"key":"R14-20250516","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R15-20250516","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R16-20250516","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GRF.0b013e31818092a3","article-title":"New approaches to external genital warts and vulvar intraepithelial neoplasia","volume":"51","author":"Kennedy","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"R17-20250516","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"R18-20250516","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R19-20250516","doi-asserted-by":"crossref","first-page":"6627531","DOI":"10.1155\/2021\/6627531","article-title":"Progression of CIN1\/LSIL HPV persistent of the cervix: actual progression or CIN3 coexistence","volume":"2021","author":"Bruno","year":"2021","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"3b","key":"R20-20250516","first-page":"1763","article-title":"Natural history of established low grade cervical intraepithelial (CIN 1) lesions","volume":"28","author":"Bansal","year":"2008","journal-title":"Anticancer Res"},{"key":"R21-20250516","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"R22-20250516","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.humpath.2017.06.014","article-title":"Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome","volume":"66","author":"Liu","year":"2017","journal-title":"Hum Pathol"},{"key":"R23-20250516","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"Brit Med J"},{"key":"R24-20250516","doi-asserted-by":"crossref","first-page":"656.e1","DOI":"10.1016\/j.ajog.2023.08.008","article-title":"Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study","volume":"229","author":"Lycke","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20250516","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/aje\/kwt077","article-title":"Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data","volume":"178","author":"Vink","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R26-20250516","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R27-20250516","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1471-0528.16081","article-title":"Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study","volume":"127","author":"Skorstengaard","year":"2020","journal-title":"BJOG"},{"key":"R28-20250516","first-page":"428","article-title":"Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins","volume":"97","author":"Reich","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R29-20250516","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2 suppl 1","key":"R31-20250516","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ygyno.2007.07.067","article-title":"Human papillomavirus infection: epidemiology and pathophysiology","volume":"107","author":"Steben","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R32-20250516"},{"key":"R33-20250516","doi-asserted-by":"crossref","first-page":"101328","DOI":"10.1016\/j.gore.2024.101328","article-title":"The burden of cervical cancer survivorship: understanding morbidity and survivorship needs through hospital admissions","volume":"51","author":"Peerenboom","year":"2024","journal-title":"Gynecol Oncol Rep"},{"key":"R34-20250516","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1188\/08.ONF.897-903","article-title":"Cervical cancer: patterns of long-term survival","volume":"35","author":"Clemmens","year":"2008","journal-title":"Oncol Nurs Forum"},{"key":"R35-20250516","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/OGX.0000000000000857","article-title":"Vulvar intraepithelial neoplasia: a review of the disease and current management","volume":"76","author":"Lauren","year":"2021","journal-title":"Obstetrics Gynecology Survey"},{"key":"R36-20250516","doi-asserted-by":"crossref","first-page":"101801","DOI":"10.1016\/j.jogoh.2020.101801","article-title":"Vulvar intraepithelial neoplasia: Classification, epidemiology, diagnosis, and management","volume":"49","author":"Lebreton","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R38-20250516","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.currproblcancer.2018.06.008","article-title":"Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: a review","volume":"42","author":"Nitecki","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"R39-20250516","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/LGT.0b013e3181ee2598","article-title":"Clinical and pathologic features of vulvar intraepithelial neoplasia in premenopausal and postmenopausal women","volume":"15","author":"Nugent","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"R40-20250516","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2017.10.029","article-title":"Vulvar intraepithelial neoplasia: risk factors for recurrence","volume":"148","author":"Satmary","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R41-20250516","doi-asserted-by":"crossref","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","article-title":"Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Abu-Rustum","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R43-20250516","first-page":"1257","article-title":"Vulvar malignancies: an interdisciplinary perspective","volume":"17","author":"Wohlmuth","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"R45-20250516","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hoc.2011.10.006","article-title":"Current management of vulvar cancer","volume":"26","author":"Fuh","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"R46-20250516","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/GME.0000000000001687","article-title":"Age-associated trends of vulvar cancer in the US","volume":"28","author":"Khadraoui","year":"2020","journal-title":"Menopause"},{"key":"R47-20250516","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/ijgc-2021-002517","article-title":"Updates in the treatment of vaginal cancer","volume":"32","author":"Jhingran","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R48-20250516","doi-asserted-by":"crossref","first-page":"e88323","DOI":"10.1371\/journal.pone.0088323","article-title":"Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance","volume":"9","author":"Nyg\u00e5rd","year":"2014","journal-title":"PLoS One"},{"key":"R50-20250516","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.3390\/curroncol29050303","article-title":"HPV vaccination: an underused strategy for the prevention of cancer","volume":"29","author":"Shapiro","year":"2022","journal-title":"Curr Oncol"},{"key":"R51-20250516","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/jcm4040614","article-title":"Safety and efficacy data on vaccines and immunization to human papillomavirus","volume":"4","author":"Kash","year":"2015","journal-title":"J Clin Med"},{"key":"R52-20250516","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1080\/21645515.2017.1346755","article-title":"Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"R53-20250516","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R54-20250516","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"key":"R55-20250516","first-page":"211","article-title":"The diagnostic value of vaginal smears in carcinoma of the uterus. 1941","volume":"121","author":"Papanicolaou","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl 12","key":"R56-20250516","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1002\/cncr.11380","article-title":"Long-term trends in cancer mortality in the United States, 1930-1998","volume":"97","author":"Wingo","year":"2003","journal-title":"Cancer"},{"key":"R57-20250516","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/LGT.0b013e3181f515a2","article-title":"Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?","volume":"15","author":"Subramaniam","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"R58-20250516","first-page":"e111","article-title":"168: cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:02:31Z","timestamp":1747386151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000930","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}